Children aged two to four should not be allowed more than one hour of "sedentary screen time" per day and infants less than one year old should not be exposed to electronic screens at all, the World Health Organization (WHO) said on Wednesday.
Novartis Chief Executive Vas Narasimhan said on Wednesday that the Swiss drugmaker is examining a price range for its Zolgensma gene therapy for spinal muscular atrophy (SMA) of between $1.5 million and $5 million per patient.
Hundreds of drones will begin delivering life-saving vaccines, blood and medicines to patients in Ghana this week in the largest scheme of its kind, the global vaccine alliance GAVI said on Wednesday.
President Donald Trump is expected to tout his fight against opioid abuse in remarks in Atlanta on Wednesday, a day after his administration brought its first related criminal charges against a major drug distributor and company executives.
Infant formula maker Bellamy's Australia said on Wednesday it won approval to sell some products in Chinese stores, easing a regulatory roadblock that had beset the company for years and sending its shares soaring.
Bellamy's Australia said on Wednesday that it had won approval to sell some of its infant formula in Chinese stores, a boost to its plan to sell to the giant market directly, which prompted a 24 percent rally in the company's shares.
China's Tencent Trusted Doctor, a venture backed by tech giant Tencent Holdings, said it has raised $250 million in a fundraising round, as investors pile into China's online private healthcare sector.
Bellamy's Australia said on Wednesday that the Chinese market regulator had released three approvals for the company's infant formula produced at its ViPlus Dairy plant in Victoria.
AbbVie Inc said on Tuesday that the U.S. Food and Drug Administration approved its Skyrizi drug as a treatment for plaque psoriasis at a time when its blockbuster psoriasis drug, Humira, faces patent pressures.
The U.S. Centers for Medicare and Medicaid Services will slightly increase coverage for expensive CAR-T cell therapies administered at certain large hospitals, and is considering other ways to pay more for the cancer treatments, the agency said on Tuesday.